Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.93 |
| ▸ | RECQL | P46063 | 2/20 | 0.93 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.89 |
| ▸ | MEN1 | O00255 | 2/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.89 |
| ▸ | USP2 | O75604 | 1/20 | 0.89 |
| ▸ | POLB | P06746 | 1/20 | 0.89 |
| ▸ | MAPT | P10636 | 1/20 | 0.89 |
| ▸ | HPGD | P15428 | 1/20 | 0.89 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.89 |
| ▸ | BLM | P54132 | 1/20 | 0.89 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.89 |
| ▸ | HMGCR | P04035 | 3/20 | 0.89 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.68 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.65 |
| ▸ | PPARG | P37231 | 6/20 | 0.65 |
| ▸ | PPARD | Q03181 | 6/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28742735 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL28742727 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL31189074 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL31189030 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL10919700 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL4863654 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL3637501 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL11525377 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL2733500 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL28742745 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4610652-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | Korea Research Institute of Bioscience and Biotechnology (KR) | 2025-09-03 | — | — | EP | claimed |
| WO-2024090998-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | 한국생명공학연구원 | 2024-05-02 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-20230026406-A1 | THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2023-01-26 | — | — | US | claimed |
| WO-2021158990-A1 | THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-08-12 | — | — | WO | claimed |
| US-20200215009-A1 | Optimized Solution for the Treatment of Alzheimer's, Stroke, Cardiovascular and other Amyloid Related Diseases | POSTREL RICHARD (US) | 2020-07-09 | — | — | US | claimed |
| US-20200078333-A1 | Healthier Aging in Domesticated Animals | POSTREL RICHARD (US) | 2020-03-12 | — | — | US | claimed |
| US-20190070166-A1 | Optimized Method for Treating and Curing Arthritis, Diabetes, Multiple Sclerosis and Other Autoimmune Disease | POSTREL RICHARD (US) | 2019-03-07 | — | — | US | claimed |
| US-20190029993-A1 | QUALITY OF LIFE EXTENSION THERAPIES RELATING TO AGING, FOOD ALLERGIES, PAIN AND REDUCED VIGOR BY MANAGING MOLECULAR, CELLULAR AND SUBCELLULAR BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OTHER ORGANELLE PROCESSES | REVIGORON LLC | 2019-01-31 | — | — | US | claimed |
| US-20190030044-A1 | HUMAN LIFE EXTENSION THERAPY THROUGH MOLECULAR, CELLULAR AND SUBCELLULAR MANAGEMENT OF BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OF OTHER ORGANELLE PROCESSES ASSOCIATED WITH THE ADVENT OF DISEASE AND/OR AGING | POSTREL RICHARD (US) | 2019-01-31 | — | — | US | claimed |
| WO-2018118197-A1 | HEALTHIER AGING IN DOMESTICATED ANIMALS | POSTREL RICHARD (US) | 2018-06-28 | — | — | WO | claimed |
| US-20180086817-A1 | Preventing, Treating or Arresting Alzheimer's, Stroke, Cardiovascular and other Amyloid Related Diseases | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 2018-03-29 | — | — | US | claimed |
| US-7365099-B2 | Reducing lipoxygenase activity by administering enzyme inhibitor | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-04-29 | — | — | US | claimed |
| US-20040146539-A1 | Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits | GUPTA SHYAM K (US) | 2004-07-29 | — | — | US | claimed |
| US-20020197301-A1 | Animal body fat control | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2002-12-26 | — | — | US | claimed |
| US-20260055280-A1 | RADIATION SENSITIVE COMPOSITIONS COMPRISING A COMBINATION OF METALS OR METALLOID COMPOUNDS | ISP INVESTMENTS LLC (US) | 2026-02-26 | — | — | US | disclosed |
| EP-4610652-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | Korea Research Institute of Bioscience and Biotechnology (KR) | 2025-09-03 | — | — | EP | disclosed |
| US-4599443-A | Unsaturated eicosanoic acids | HOFFMANN-LA ROCHE INC. (US) | 1986-07-08 | — | — | US | disclosed |
| US-4500462-A | ANTIALLERGENS, ANTIHISTIMINE, ANTIINFLAMMATORY AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1985-02-19 | — | — | US | disclosed |
| US-4345084-A | ANTIHISTAMINES, ANTIALLERGENS | HOFFMANN-LA ROCHE INC. (US) | 1982-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055280-A1 | RADIATION SENSITIVE COMPOSITIONS COMPRISING A COMBINATION OF METALS OR METALLOID COMPOUNDS | BRCA1, ATR, ATM | TDP1 2348/4885RECQL 679/4885PTPN7 2525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.